Literature DB >> 32022592

Respiratory defects in the CrtapKO mouse model of osteogenesis imperfecta.

Milena Dimori1, Melissa E Heard-Lipsmeyer1, Stephanie D Byrum2,3, Samuel G Mackintosh2, Richard C Kurten1, John L Carroll4, Roy Morello1,5,6.   

Abstract

Respiratory disease is a leading cause of mortality in patients with osteogenesis imperfecta (OI), a connective tissue disease that causes severely reduced bone mass and is most commonly caused by dominant mutations in type I collagen genes. Previous studies proposed that impaired respiratory function in OI patients was secondary to skeletal deformities; however, recent evidence suggests the existence of a primary lung defect. Here, we analyzed the lung phenotype of Crtap knockout (KO) mice, a mouse model of recessive OI. While we confirm changes in the lung parenchyma that are reminiscent of emphysema, we show that CrtapKO lung fibroblasts synthesize type I collagen with altered posttranslation modifications consistent with those observed in bone and skin. Unrestrained whole body plethysmography showed a significant decrease in expiratory time, resulting in an increased ratio of inspiratory time over expiratory time and a concomitant increase of the inspiratory duty cycle in CrtapKO compared with WT mice. Closed-chest measurements using the forced oscillation technique showed increased respiratory system elastance, decreased respiratory system compliance, and increased tissue damping and elasticity in CrtapKO mice compared with WT. Pressure-volume curves showed significant differences in lung volumes and in the shape of the curves between CrtapKO mice and WT mice, with and without adjustment for body weight. This is the first evidence that collagen defects in OI cause primary changes in lung parenchyma and several respiratory parameters and thus negatively impact lung function.

Entities:  

Keywords:  Crtap; collagen; lung; osteogenesis imperfecta; respiratory function

Mesh:

Substances:

Year:  2020        PMID: 32022592      PMCID: PMC7191481          DOI: 10.1152/ajplung.00313.2019

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  62 in total

1.  AN ANALYSIS OF PRESSURE-VOLUME CHARACTERISTICS OF THE LUNGS.

Authors:  E SALAZAR; J H KNOWLES
Journal:  J Appl Physiol       Date:  1964-01       Impact factor: 3.531

Review 2.  Lung extracellular matrix and fibroblast function.

Authors:  Eric S White
Journal:  Ann Am Thorac Soc       Date:  2015-03

3.  Cardiovascular disease in patients with osteogenesis imperfecta - a nationwide, register-based cohort study.

Authors:  Lars Folkestad; Jannie Dahl Hald; Jeppe Gram; Bente L Langdahl; Anne Pernille Hermann; Axel Cp Diederichsen; Bo Abrahamsen; Kim Brixen
Journal:  Int J Cardiol       Date:  2016-09-30       Impact factor: 4.164

4.  Classification of osteogenesis imperfect.

Authors:  D O Sillence; D L Rimoin
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

Review 5.  Extracellular matrix in lung development, homeostasis and disease.

Authors:  Yong Zhou; Jeffrey C Horowitz; Alexandra Naba; Namasivayam Ambalavanan; Kamran Atabai; Jenna Balestrini; Peter B Bitterman; Richard A Corley; Bi-Sen Ding; Adam J Engler; Kirk C Hansen; James S Hagood; Farrah Kheradmand; Qing S Lin; Enid Neptune; Laura Niklason; Luis A Ortiz; William C Parks; Daniel J Tschumperlin; Eric S White; Harold A Chapman; Victor J Thannickal
Journal:  Matrix Biol       Date:  2018-03-08       Impact factor: 11.583

6.  Instillation and Fixation Methods Useful in Mouse Lung Cancer Research.

Authors:  Nathachit Limjunyawong; Jason Mock; Wayne Mitzner
Journal:  J Vis Exp       Date:  2015-08-31       Impact factor: 1.355

7.  Ribcage deformity and the altered breathing pattern in children with osteogenesis imperfecta.

Authors:  Antonella LoMauro; Paolo Fraschini; Simona Pochintesta; Marianna Romei; Maria G D'Angelo; Andrea Aliverti
Journal:  Pediatr Pulmonol       Date:  2018-05-15

8.  Temporal dynamics of the developing lung transcriptome in three common inbred strains of laboratory mice reveals multiple stages of postnatal alveolar development.

Authors:  Joel H Graber; Carol J Bult; Kyle J Beauchemin; Julie M Wells; Alvin T Kho; Vivek M Philip; Daniela Kamir; Isaac S Kohane
Journal:  PeerJ       Date:  2016-08-09       Impact factor: 2.984

9.  Cardiopulmonary dysfunction in the Osteogenesis imperfecta mouse model Aga2 and human patients are caused by bone-independent mechanisms.

Authors:  Frank Thiele; Christian M Cohrs; Armando Flor; Thomas S Lisse; Gerhard K H Przemeck; Marion Horsch; Anja Schrewe; Valerie Gailus-Durner; Boris Ivandic; Hugo A Katus; Wolfgang Wurst; Catherine Reisenberg; Hollis Chaney; Helmut Fuchs; Wolfgang Hans; Johannes Beckers; Joan C Marini; Martin Hrabé de Angelis
Journal:  Hum Mol Genet       Date:  2012-05-15       Impact factor: 6.150

Review 10.  Invasive and noninvasive methods for studying pulmonary function in mice.

Authors:  Thomas Glaab; Christian Taube; Armin Braun; Wayne Mitzner
Journal:  Respir Res       Date:  2007-09-14
View more
  4 in total

Review 1.  Osteogenesis imperfecta: an update on clinical features and therapies.

Authors:  Ronit Marom; Brien M Rabenhorst; Roy Morello
Journal:  Eur J Endocrinol       Date:  2020-10       Impact factor: 6.664

2.  Airway compliance measurements in mouse models of respiratory diseases.

Authors:  Annette Robichaud; Liah Fereydoonzad; Samuel L Collins; Jeffrey Martin Loube; Yumiko Ishii; Maureen R Horton; James G Martin; Wayne Mitzner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-19       Impact factor: 6.011

3.  Haploinsufficiency of Col5a1 causes intrinsic lung and respiratory changes in a mouse model of classical Ehlers-Danlos syndrome.

Authors:  Jordan Fett; Milena Dimori; John L Carroll; Roy Morello
Journal:  Physiol Rep       Date:  2022-04

4.  Pathophysiology of respiratory failure in patients with osteogenesis imperfecta: a systematic review.

Authors:  S Storoni; S Treurniet; D Micha; M Celli; M Bugiani; J G van den Aardweg; E M W Eekhoff
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.